Details
Title
Pathophysiology and clinical management of pellagra — a reviewJournal title
Folia Medica CracoviensiaYearbook
2021Volume
Vol. 61Issue
No 3Affiliation
Hałubiec, Przemysław : Department of Dermatology, Jagiellonian University Medical College, Kraków, Poland ; Leończyk, Monika : Department of Dermatology, Jagiellonian University Medical College, Kraków, Poland ; Staszewski, Filip : Department of Dermatology, Jagiellonian University Medical College, Kraków, Poland ; Łazarczyk, Monika : Department of Dermatology, Jagiellonian University Medical College, Kraków, Poland ; Jaworek, Andrzej Kazimierz : Department of Dermatology, Jagiellonian University Medical College, Kraków, Poland ; Wojas-Pelc, Anna : Department of Dermatology, Jagiellonian University Medical College, Kraków, PolandAuthors
Keywords
pellagra ; niacin ; vitamin B3 ; tryptophanDivisions of PAS
Nauki MedyczneCoverage
125-137Publisher
Oddział PAN w Krakowie; Uniwersytet Jagielloński – Collegium MedicumBibliography
1. Karthikeyan K., Thappa D.M.: Pellagra and skin. Int J Derm. 2002; 41 (8): 476–481.2. Cao S., Wang X., Cestodio K.: Pellagra, an Almost-Forgotten Differential Diagnosis of Chronic Diarrhea: More Prevalent Than We Think. Nutrition in Clinical Practice. Nutr Clin Pract. 2019; 35 (5): 860–863.
3. Hegyi J., Schwartz R.A., Hegyi V.: Pellagra: Dermatitis, dementia, and diarrhea. Int J Derm. 2004; 43 (1): 1–5.
4. Prinzo Z.W.: Pellagra and its prevention and control in major emergencies. WHO. 2000; NHD/00.01: 1–32.
5. Narasimha V.L., Ganesh S., Reddy S., et al.: Pellagra and Alcohol Dependence Syndrome: Findings From a Tertiary Care Addiction Treatment Centre in India. MCA. 2019; 54 (2): 148–151.
6. Redzic S., Gupta V.: Niacin Deficiency. StatPearls 2021.
7. Elvehjem C.A., Madden R.J., Strong F.M., Woolley D.W.: Relation of Nicotinic Acid And Nicotinic Acid Amide To Canine Black Tongue. J Am Chem Soc. 1937; 59 (9): 1767–1768.
8. Stratigos J.D., Katsambas A.: Pellagra: a still existing disease. Br J Dermatol. 1977; 96 (1): 99–106.
9. Tymoczko J.L., Berg J.M., Stryer L.: Biochemistry. A Short Course. W.H. Freeman Company 2013.
10. Jacobson M.K., Jacobson E.L.: Vitamin B3 in Health and Disease: Toward the Second Century of Discovery. In: Methods in Molecular Biology. Methods Mol Biol. 2018; 1813: 3–8.
11. Horwitt M.K., Harvey C.C., Rothwell W.S., Cutler J.L., Haffron D.: Tryptophan-Niacin Relationships in Man. J Nutr. 1956; 60 (Suppl. 1): 1–43.
12. Badawy A.A.-B.: Pellagra and Alcoholism: A Biochemical Perspective. Alcohol Alcohol. 2014; 49 (3): 238–250.
13. Carpenter K.J.: The Relationship of Pellagra to Corn and the Low Availability of Niacin in Cereals. Experientia Suppl. 1983; 44: 197–222.
14. Judd L.E., Poskitt B.L.: Pellagra in a patient with an eating disorder. Br J Dermatol. 1991; 125 (1): 71–72.
15. Yamaguchi S., Miyagi T., Sogabe Y., et al.: Depletion of Epidermal Langerhans Cells in the Skin Lesions of Pellagra Patients. Am J Dermatopath. 2017; 39 (6): 428–432.
16. Kipsang J.K., Choge J.K., Marinda P.A., Khayeka-Wandabwa C.: Pellagra in isoniazid preventive and antiretroviral therapy. IDCases. 2019; 17: e00550.
17. Chauchan R., Vyas P., Mabena D.: Pellagra in an HIV-infected Individual: a Cause of Chronic Diarrhoea. Med J Armed Forces India. 1997; 53 (4): 303–304.
18. Murray R.K., Granner D.K., Rodwell V.W.: Harper’s Illustrated Biochemistry, Twenty-Seventh Edition. The McGraw-Hill Companies 2012.
19. Shah G.M., Shah R.G., Veillette H., Kirkland J.B., Pasieka J.L., Warner R.R.P.: Biochemical Assessment of Niacin Deficiency Among Carcinoid Cancer Patients. Am J Gastroenterol. 2005; 100 (10): 2307– 2314.
20. Periyasamy S., John S., Padmavati R., et al.: Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association Study. JAMA Psychiatry. 2019; 76 (10): 1026–1034.
21. Sugita K., Ikenouchi-Sugita A., Nakayama Y., et al.: Prostaglandin E2 is critical for the development of niacin-deficiency-induced photosensitivity via ROS production. Sci Rep. 2013; 3 (1): 2973.
22. Wan P., Moat S., Anstey A.: Pellagra: a review with emphasis on photosensitivity. Br J Dermatol. 2011; 164 (6): 1188–1200.
23. Taylor R.G., Levy H.L., McInnes R.R.: Histidase and histidinemia. Clinical and molecular considerations. Mol Biol Med. 1991; 8 (1): 101–116.
24. Beretich G.R. Jr.: Do high leucine/low tryptophan dieting foods (yogurt, gelatin) with niacin supplementation cause neuropsychiatric symptoms (depression) but not dermatological symptoms of pellagra? Med Hypotheses. 2005; 65 (3): 628–629.
25. Savvidou S.: Pellagra: A Non-Eradicated Old Disease. Clin Pract. 2014; 4 (1): 637.
26. Duncan K.O., Bolognia J.L., Schaffer J.V., Ko C.J.: Dermatology Essentials. Elsevier 2014.
27. Crook M.A.: The importance of recognizing pellagra (niacin deficiency) as it still occurs. Nutrition. 2014; 30 (6): 729–730.
28. Szepietowski J., Wiśnicka B.: Zmiany skórne u chorych z zespołami otępiennymi. Polska Medycyna Paliatywna. 2004; 3 (1): 33–37.
29. Tadil S., Darla R.: Pemphigus Pellagrosus masquerading as cutaneous adverse drug reaction. Int J Derm. 2020; 2 (1): 34–37.
30. Zhang X.-J., Wang A.-P., Shi T.-Y., et al.: The psychosocial adaptation of patients with skin disease: a scoping review. BMC Public Health. 2019; 19: 1404.
31. Roosta N., Black D., Peng D., Riley L.: Skin disease and stigma in emerging adulthood: impact on healthy development. J Cutan Med Surg. 2010; 14 (6): 285–290.
32. Yuksel P.E., Sen. S., Aydin F., Senturk N., Sen N., Cengiz N., et al.: Phenobarbital-induced pellagra resulted in death. Cutan Ocul Toxicol. 2013; 33 (1): 76–78.
33. Mousa T.Y., Mousa O.Y.: Nicotinic Acid Deficiency. StatPearls 2020. 34. Wei W., Bo L.: Case report of mental disorder induced by niacin deficiency. Shanghai Arch Psychiatry. 2012; 24 (6): 352–354.
35. Niacin. Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Niacin-HealthProfessional/ (access on 1st February 2021).
36. Piqué-Duran E., Pérez-Cejudo J.A., Cameselle D., Palacios-Llopis S., García-Vázquez O.: Pellagra: A Clinical, Histopathological, and Epidemiological Study of 7 Cases. Actas Dermosifiliogr. 2012; 103 (1): 51–58.
37. Frank G.P., Voorend D.M., Chamdula A., van Oosterhout J.J., Koop K.: Pellagra: A non-communicable disease of poverty. Trop Doct. 2012; 42 (3): 182–184.
38. Milovanović D., Djukić A., Stepanović R., Peković D., Vranjesecić D.: [Hatnup disease (report of 2 cases in one family)]. Srp Arh Celok Lek. 2000; 128 (3–4): 97–103.
39. Vanucchi H., Favaro F.M., Cunha D.F., Marchini J.F.: Assessment of zinc nutritional status of pellagra patients. Alcohol Alcohol. 1995; 30 (3): 297–302.
40. Wang S.Q., Balagula Y., Osterwalder U.: Photoprotection: a Review of the Current and future Technologies. Dermatol Ther. 2010; 23 (1): 31–47.
41. Pellagra Treated With Tryptophan. Nutr Rev. 1987; 45 (7): 142–148.
42. Allen J.A., Peterson A., Sufit R., et al.: Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. Arthritis Rheum. 2011; 63 (11): 3633–3639.
43. Burgdorf W.H.C., Plewig G., Wolff H.H., Landthaler M.: Dermatologia Braun-Falco. Wydawnictwo Czelej 2017. 44. Bilgili S.G., Karadag A.S., Calka O., Altun F.: Isoniazid-induced pellagra. Cutan Ocul Toxicol. 2011; 30 (4): 317–319.